Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia and severe sepsis

Semin Respir Crit Care Med. 2006 Feb;27(1):29-33. doi: 10.1055/s-2006-933671.

Abstract

The triggering receptor expressed on myeloid cells (TREM)-1 is a recently identified molecule involved in the inflammatory response. It belongs to the immunoglobulin superfamily and is expressed on the surface of neutrophils, mature monocytes, and macrophages. The engagement of TREM-1 synergizes with the Toll-like receptors signaling pathway in amplifying the inflammatory response mediated by several microbial components. The expression of the membrane-bound TREM-1 is strongly upregulated on monocytes during sepsis. Besides its membranous form, a soluble counterpart of TREM-1 exists that is specifically released during several infectious processes. The measurement of that soluble form in biological fluids may be useful as a diagnostic tool, especially during severe sepsis and pneumonia. Moreover, the evolutionary pattern of TREM-1 may be interesting during the follow-up of septic patients.

Publication types

  • Review

MeSH terms

  • Biomarkers / metabolism
  • Humans
  • Inflammation / metabolism*
  • Membrane Glycoproteins / metabolism*
  • Pneumonia, Bacterial / diagnosis*
  • Pneumonia, Bacterial / metabolism
  • Receptors, Immunologic / metabolism*
  • Sepsis / diagnosis*
  • Sepsis / metabolism
  • Triggering Receptor Expressed on Myeloid Cells-1

Substances

  • Biomarkers
  • Membrane Glycoproteins
  • Receptors, Immunologic
  • TREM1 protein, human
  • Triggering Receptor Expressed on Myeloid Cells-1